- Home
- ZLAB vs FIZZ Comparison
ZLAB vs FIZZ Comparison
Compare ZLAB & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- FIZZ
- Stock Information
- Founded
- ZLAB 2013
- FIZZ 1985
- Country
- ZLAB China
- FIZZ United States
- Employees
- ZLAB N/A
- FIZZ N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- FIZZ Beverages (Production/Distribution)
- Sector
- ZLAB Health Care
- FIZZ Consumer Staples
- Exchange
- ZLAB Nasdaq
- FIZZ Nasdaq
- Market Cap
- ZLAB 3.6B
- FIZZ 3.9B
- IPO Year
- ZLAB 2017
- FIZZ 1991
- Fundamental
- Price
- ZLAB $32.91
- FIZZ $37.08
- Analyst Decision
- ZLAB Buy
- FIZZ Strong Sell
- Analyst Count
- ZLAB 6
- FIZZ 1
- Target Price
- ZLAB $57.22
- FIZZ $39.00
- AVG Volume (30 Days)
- ZLAB 725.2K
- FIZZ 283.0K
- Earning Date
- ZLAB 11-11-2025
- FIZZ 09-11-2025
- Dividend Yield
- ZLAB N/A
- FIZZ N/A
- EPS Growth
- ZLAB N/A
- FIZZ 0.66
- EPS
- ZLAB N/A
- FIZZ 1.98
- Revenue
- ZLAB $427,799,000.00
- FIZZ $1,202,396,000.00
- Revenue This Year
- ZLAB $41.60
- FIZZ $2.80
- Revenue Next Year
- ZLAB $53.42
- FIZZ $2.19
- P/E Ratio
- ZLAB N/A
- FIZZ $18.66
- Revenue Growth
- ZLAB 32.56
- FIZZ 0.46
- 52 Week Low
- ZLAB $23.70
- FIZZ $36.14
- 52 Week High
- ZLAB $44.34
- FIZZ $50.51
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.59
- FIZZ 32.36
- Support Level
- ZLAB $33.76
- FIZZ $36.14
- Resistance Level
- ZLAB $34.72
- FIZZ $38.00
- Average True Range (ATR)
- ZLAB 0.86
- FIZZ 0.82
- MACD
- ZLAB 0.20
- FIZZ 0.22
- Stochastic Oscillator
- ZLAB 51.19
- FIZZ 38.19
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).